publication . Article . 2017

Prevalence and risk factors for hepatitis C viral infection amongst a cohort of irish drug users attending a drug treatment centre for agonist opioid treatment (AOT)

Keegan, D.; Crowley, D.; Eamon Laird; Hout, M. C.;
  • Published: 01 Jan 2017
  • Country: United Kingdom
Abstract
Background: Injecting drug use (IDU) is a major driver of the European hepatitis C virus (HCV) epidemic. National data on prevalence of HCV amongst Irish drug users remains confined to certain treatment sites and prison settings. Aim: To examine the prevalence of HCV infection and risk factors associated with infection among the 228 patients attending agonist opioid treatment (AOT) in a clinic in Dublin. Methods: A retrospective cross-sectional study was conducted using data collected from Health Research Board (HRB) forms and standardised written and electronic assessment forms routinely completed on treatment initiation. Results: The prevalence of HCV infectio...
Subjects
free text keywords: RA0421
56 references, page 1 of 4

Allwright S, Barry J, Reynolds SR, Thornton L, Bradley F, Parry JV. (2000) Prevalence of antibodies to hepatitis B, hepatitis C and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey. BMJ, 323:1209-1213. [OpenAIRE]

Artenie A.A., Roy E., Zang G., Jutras-Aswad D., Bamvita J.-M., Puzhko S., Daniel M, Bruneau J. (2015).

Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention. Int J Drug Pol 26(10): 970-975.

Aspinall E.J, Corson S, Doyle J.S, Grebely J, Hutchinson S.J, Dore G.J, Goldberg D.J., Hellard, M.E., (2013).

Treatment of hepatitis C virus infection among peoplewho actively inject drugs: a systematic review and meta-analysis. Clin Infect.Dis. 57: 80-89.

Brennan E, Thornton L, Connell J, O'NeillW, O'Riordan J (2004). Epidemiology of hepatitis C infection in Ireland. Epi-Insight 5:5.

(2011). Is nonmedical prescription opiate use a unique form of illicit drug use? Addict Behav. 36(1-2):79-86.

Conroy A, Coughlan S, Dooley S, Hall WW (2003).

Prevalence of hepatitis C genotypes in Ireland. Ir J Med Sci, 172(2, Supplement 1): 15.

Cox G, Robinson, J. (2008) Needle Exchange Provision in Ireland: The Context, Current Levels of Service Provision and Recommendations. A Joint Report by the National Drugs Strategy Team and the National Advisory Committee on Drugs. Dublin: NACD.

Doyle J.S, Aspinall E.J, Hutchinson S.J, Quinn B, Gore C, Wiktor S.Z., Hellard ME. (2015). Global policy and access to new hepatitis C therapies for people who inject drugs. Int J Drug Pol, 26(11): 1064-1071. [OpenAIRE]

9. Drummond A, Codd M, Donnelly N (2014) Study on the prevalence of drug use, including intravenous drug use, and blood-borne viruses among the Irish prisoner population. Dublin: National Advisory Committee on Drugs and Alcohol. [OpenAIRE]

10. EMCDDA (2013): European Drug Report 2013: Trends and development. Lisbon: EMCDDA.

11. Friedman S.R, Sandoval M, Mateu-Gelabert P, Meylakhs P, Des Jarlais D.C. (2011).Symbiotic goals and the prevention of blood-borne viruses among injection drug users. Subst Use Misuse, 46(2-3): 307-315.

12. Galander T, Rosalim, J, Betts-Symonds G, Scully, M (2014). A survey of patients on methadone programmes in Wheatefild Prison, Dublin, Ireland. Heroin Addict Rel Clin Prob, 16 (2): 17-22.

56 references, page 1 of 4
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue